The company was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco, and aims to generate therapeutic compositions of specific neurons for targeted delivery into the injured nervous system. Their research has shown that certain subpopulations of neurons have the unique ability to repair dysregulated neural circuits. Neurona's team of scientists, advisors, and directors is working to accelerate breakthrough treatments for patients with unmet medical needs by developing neural cell therapies with single-dose curative potential for chronic neurological disorders.